Genetic testing is revolutionizing the way we approach clinical trials, particularly in the realm of rare diseases. Not only does it provide patients with a diagnosis, but it also helps families understand their risk of developing certain conditions and is often a crucial entry criterion for clinical trial participation.
As a leader in leveraging genetic testing in clinical trials, we’ve had the privilege of guiding numerous sponsors through the process. Along the way, we’ve identified common questions and concerns that arise when utilizing genetic testing.
Our expert, Derek Ansel, MS, CGC, Vice President, Therapeutic Strategy Lead, Rare Disease, has compiled the answers to our most frequently asked questions about genetic testing in clinical trials. Check out the FAQ today.
